News | Nuclear Imaging | June 14, 2016

Philips Showcases Nuclear Imaging Solutions at SNMMI 2016

Highlights of company’s offerings include time-of-flight capabilities on Vereos digital PET/CT, advanced data sharing via IntelliSpace 8.0

Philips, SNMMI 2016, Vereos digital PET/CT, time-of-flight, IntelliSpace 8.0, nuclear imaging

June 14, 2016 — Philips announced it would be showcasing a variety of nuclear imaging solutions at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2016 Annual Meeting, June 11-15 in San Diego.

Nuclear medicine technology has significantly evolved over the years – growing from scanner-only equipment to solutions that integrate quality, quantification and analytics. Ten years ago, also in San Diego, Philips introduced the first commercial time-of-flight positron emission tomography (PET)/computed tomography (CT). Over the last decade, this technology has continued to improve and today, time-of-flight is faster, better and digital. This year, over 20 oral and poster sessions featuring Philips’ digital photon counting PET system will be presented at the SNMMI meeting, highlighting the technology’s full range of capabilities and Philips’ work with academic partners.

“The Wright Center of Innovation team at The Ohio State University and Philips have been very successful partners in the clinical evaluation of the next-generation digital PET/CT,” said Michael V. Knopp, M.D., Ph.D., professor of radiology at The Ohio State University Wexner Medical Center. “In this year’s SNMMI Annual Meeting, we will present over 20 scientific presentations and posters on these efforts demonstrating performance and benefits of PET digital photon counting in the areas of lesion detectability, radiation dose management and quantitative imaging.”

As our population continues to age and exponentially grows in the coming years, coinciding with the prevalence of multiple chronic and complex diseases such as cancer, dementia and cardiac diseases, health imaging will require a more integrated and interdisciplinary approach toward treatment. Given the unique clinical insights it provides, molecular imaging will play even more of a critical role in addressing complex diseases – as a result, the advanced data and analytics found in these technologies will be essential to improving patient care.

Philips’ SNMMI exhibit will feature the latest solutions and technologies driving nuclear medicine, and will highlight the following milestones:

  • A decade of Time of Flight – Today, time-of-flight is available in products such as Vereos, which Philips calls the world’s first fully digital PET/CT. Time-of-flight technology is now bridging innovation with digital architecture available in Philips solutions.
  • Advanced data sharing – Data sharing gives physicians the power to visualize, diagnose and communicate across clinical domains and imaging modalities with one automated workflow. Philips’ latest edition of its advanced data sharing, analytics and visualization platform, Intellispace 8.0, helps physicians detect, diagnose and follow up on treatment of diseases, offering a comprehensive advanced visualization suite for multimodality tumor tracking, characterization and assessment.
  • Flexibility of PET/CT – Philips PET/CT systems allow physicians to go beyond current limitations in standard PET/CT imaging, with capabilities such as digital imaging, and can now meet a wide range of clinical and economic needs in CT lung cancer screening.

For more information: www.philips.com

Related Content

MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...
Feature | PET Imaging | November 07, 2018 | By Greg Freiherr
Positron emission tomography (PET) is getting ready to venture outside oncology, cardiology and mainstream neurology....
Podcast | PET Imaging | November 07, 2018
PET is getting ready to venture outside oncology, cardiology and mainstream neurology.
A PET/CT head and neck cancer scan.

A PET/CT head and neck cancer scan.

Feature | Nuclear Imaging | November 05, 2018 | By Sabyasachi Ghosh
“Experimental validation implemented in real-life situations and not theoretical claims exaggerating small advantages
Deaconess Health System Chooses Sectra as Enterprise Imaging Vendor
News | Enterprise Imaging | November 02, 2018
International medical imaging information technology (IT) and cybersecurity company Sectra will install its enterprise...
Carestream Spotlights Healthcare IT and Imaging Systems at RSNA 2018
News | Information Technology | October 31, 2018
Carestream announced it will be displaying several imaging and healthcare information technology (IT) offerings at the...
PET Imaging Offers New Possibilities in Chronic Liver Disease Management

Hepatic 18F-FDG, 18F-FAC, and 18F-DFA accumulation are affected in a mouse model of autoimmune hepatitis. (A) Histochemical and immunohistochemical analyses of liver sections from vehicle- and ConA-treated mice. Scale bars represent 50 microns. Transverse PET/CT images (B) and quantification (C) of vehicle- and ConA-treated mice injected with 18F-FDG, 18F-FAC, and 18FDFA. Livers are outlined in a white dotted line. Quantification represents radiotracer accumulation in the liver normalized to a background organ. Image courtesy of Salas J.R., Chen B.Y., Wong A., et al.

News | PET Imaging | October 24, 2018
While liver biopsies are powerful and reliable, they are also invasive, painful, limited and subject to complications....
CORAR Supports Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2018
News | Radiopharmaceuticals and Tracers | October 12, 2018
October 12, 2018 — The Council on Radionuclides and Radiopharmaceuticals Inc.
Huntsman Cancer Institute Installs First Preclinical nanoScan 3T PET/MRI in U.S.
News | PET-MRI | October 10, 2018
The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of Utah in Salt Lake...
Cullman Regional Medical Center

Cullman Regional Medical Center (Alabama) is a 145-bed medical center serving more than 175,000 residents in a six-county area and recognized as one of the region’s finest medical facilities.

Sponsored Content | Case Study | PACS | October 05, 2018
When Cullman Regional Medical Center in Alabama decided to switch from 2-D